V. Komogorova

SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study

Elizaveta V. Romanova, G. Efimov, D. Logunov, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study.

Elizaveta V. Romanova, G. Efimov, D. Logunov, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Respiratory syncytial virus upregulates IL-33 expression in mouse model of virus-induced inflammation exacerbation in OVA-sensitized mice and in asthmatic subjects.

A. Nikonova, M. Khaitov, A. Dvornikov, 2020, Cytokine.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study

Elizaveta V. Romanova, G. Efimov, D. Logunov, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

A prospective study of the protective effect of SARS-CoV-2-specific antibodies and T cells in Moscow residents

A. Mohammad, N. Pinegina, A. Deryabin, 2021, medRxiv.